Search research articles
Contact Us
Filters
Showing results (311-320 of 376) with videos related to
Page
of 38
Sort By:
Veterinary Microbiology
|
October 2, 2018
Risk factors associated with hepatitis E virus in pigs from different production systems
Pedro Lopez-Lopez, Maria de Los Angeles Risalde, Mario Frias, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
CNS Neuroscience & Therapeutics
|
April 16, 2018
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
Bibiana Quirant-Sánchez, José V Hervás-García, Aina Teniente-Serra, et al.
Mediators of Inflammation
|
July 27, 2019
Th1Th17<sub>CM</sub> Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
Bibiana Quirant-Sánchez, Silvia Presas-Rodriguez, María José Mansilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 18, 2023
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
Bruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Journal of Clinical Medicine
|
June 13, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Frontiers in Neuroscience
|
September 26, 2019
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Hugo Gonzalo, Lara Nogueras, Anna Gil-Sánchez, et al.
Journal of Cosmetic Dermatology
|
May 6, 2026
International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits
Peter Bjerring, Zoe D Draelos, Sabrina G Fabi, et al.
Journal of Personalized Medicine
|
December 24, 2021
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab
Júlia Granell-Geli, Cristina Izquierdo-Gracia, Ares Sellés-Rius, et al.
Page
of 38
Search research articles
Search
Showing results (311-320 of 376) with videos related to
Sort By:
Page
of 38
Veterinary Microbiology
|
October 2, 2018
Risk factors associated with hepatitis E virus in pigs from different production systems
Pedro Lopez-Lopez, Maria de Los Angeles Risalde, Mario Frias, et al.
Scientific Reports
|
November 8, 2023
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
Cristina González Mingot, Sonia Santos Lasaosa, Laura Colàs Campàs, et al.
CNS Neuroscience & Therapeutics
|
April 16, 2018
Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients
Bibiana Quirant-Sánchez, José V Hervás-García, Aina Teniente-Serra, et al.
Mediators of Inflammation
|
July 27, 2019
Th1Th17<sub>CM</sub> Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment
Bibiana Quirant-Sánchez, Silvia Presas-Rodriguez, María José Mansilla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 18, 2023
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
Bruno Brochet, Alessandra Solari, Jeannette Lechner-Scott, et al.
Journal of Clinical Medicine
|
June 13, 2025
Profile of Cytokines Associated with SARS-CoV2 Seropositivity in Multiple Sclerosis Patients and Its Persistence over Six Months
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Bibiana Quirant-Sánchez, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 23, 2013
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS
C Ramo-Tello, L Grau-López, M Tintoré, et al.
Frontiers in Neuroscience
|
September 26, 2019
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Hugo Gonzalo, Lara Nogueras, Anna Gil-Sánchez, et al.
Journal of Cosmetic Dermatology
|
May 6, 2026
International Expert Consensus on Integrated Skincare Active Ingredients for Pretreatment and Posttreatment Use With Medical Aesthetic Procedures to Enhance Skin Benefits
Peter Bjerring, Zoe D Draelos, Sabrina G Fabi, et al.
Journal of Personalized Medicine
|
December 24, 2021
Assessing Blood-Based Biomarkers to Define a Therapeutic Window for Natalizumab
Júlia Granell-Geli, Cristina Izquierdo-Gracia, Ares Sellés-Rius, et al.
Page
of 38